Oral toxicity is frequent limitation of mTOR therapy
Oral mucositis is a frequent complication in patients taking mTOR inhibitors and a major reason for dose reductions and discontinuations in clinical trials, according to a review of this class of cancer drugs.
No comments:
Post a Comment